Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company ®, today announced that South Nassau Communities Hospital (South Nassau), a 435-bed teaching hospital located in Oceanside, NY, has selected the company’s Sunrise Enterprise™ suite of integrated clinical solutions. South Nassau’s technology initiative, which includes Eclipsys’ leading computerized physician order entry (CPOE) solution, will support creating a unified electronic system throughout departments to transform care delivery processes for safer care, greater efficiency and improved outcomes. The investment in advanced technology also will support South Nassau in its goal to meet the recently finalized “Meaningful Use” requirements of the American Recovery and Reinvestment Act (ARRA) of 2009 to qualify for stimulus funds. South Nassau’s plans call for deployment of Eclipsys’ CPOE solution to support evidence-based practices and clinical decision making, along with the company’s integrated pharmacy solution, Sunrise Pharmacy™. Working in concert via a single database, the solution enables integrated handoffs between clinicians and pharmacists resulting in fewer errors and accelerated time to medication treatment. Deployment of Eclipsys’ clinical documentation solution, e-prescribing and orders reconciliation solutions will contribute to further clinical efficiency, medication safety and care team collaboration. In combination, these new solutions will create a single electronic health record (EHR) across care venues to improve care team efficiency and clinical decision making. “This significant technology initiative continues our unwavering commitment to provide the highest quality healthcare services to our community,” said John Mertz, chief information officer at South Nassau. “We believe that technology will continue to exponentially replace healthcare’s dependence on paper-based, manual processes. Eclipsys’ proven track record in helping clients achieve deep physician adoption of its systems gave us confidence we chose the right technology partner as an essential step toward providing truly excellent patient care and to meet the expected meaningful use requirements by specified timelines.” Partnering with a Leader in CPOE to Meet Meaningful Use The Center for Medicare and Medicaid Services’(CMS) final rule on ‘meaningful use’ of an EHR includes the requirement that at least 30 percent of a hospital’s patients with a medication order must have that order entered through a CPOE solution. In Stage 2 of ‘meaningful use,’ scheduled to occur in 2013, the percentage of CPOE medication orders requirement doubles to 60 percent. Eclipsys estimates its U.S. client base has achieved on average a 70-percent CPOE adoption rate. In fact, according to the 2010 CPOE study entitled “CPOE: Traffic Jams on the Road to Meaningful Use” issued by KLAS Enterprises, LLC, Eclipsys is recognized as a leader in CPOE and among the most ‘meaningful use-ready’ vendors. In the same report, Eclipsys was recognized as having the greatest percentage of its client base live with CPOE, highest customer satisfaction with CPOE, and greatest percentage of significant or deep physician CPOE users in recently live hospitals.
Additional Key Solutions and Services for ‘Meaningful Use’With a transition to a comprehensive electronic system, South Nassau also selected Eclipsys’ Sunrise Clinical Analytics™ solution to leverage the rich healthcare data flowing through its EHR to support optimizing care processes. Near real-time analytics and reporting capabilities will support improved care team decisions, as well as patient safety and other quality initiatives. In addition, Eclipsys’ Sunrise Patient Portal™ will provide South Nassau patients with self-service functionality, such as internet access to updated health information and the ability to schedule doctor appointments. This level of patient connectivity and access to information is another facet providers must demonstrate to meet ARRA meaningful use requirements. South Nassau plans to utilize Eclipsys’ “speed to value” implementation approach, accelerating the activation to help meet the specified ARRA timeline requirements and maximize stimulus payment opportunities. The approach leverages Eclipsys’ rich client knowledge to provide more than 1,000 suggested design decisions to help reduce deployment cycle time and enable clients to focus on value-added activities during the implementation. South Nassau will also use Eclipsys’ remote hosting services to support managing its new technology infrastructure, delivering powerful CPU processing, fast storage and dedicated point-to-point communications. “We are very pleased that South Nassau Communities Hospital chose to partner with Eclipsys as they pursue their goal of promoting the best quality of care for their community while leveraging the opportunity to receive federal stimulus dollars,” said Jay Deady, Eclipsys’ executive vice president of Client Solutions. “Eclipsys understands that physician adoption of technology is the key to improving patient outcomes and reducing costs, which is the ultimate goal behind ARRA. In combination with our proven “speed to value” implementation methodology, we are confident that South Nassau will quickly and effectively make great strides in its ARRA and clinical quality goals.”
About South Nassau Communities HospitalSouth Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 875 physicians and 2,800 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services. In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty and is the only hospital on Long Island with the Novalis Tx and Gamma Knife radiosurgery technologies. South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery. For more information, see www.southnassau.org. About the CPOE: Traffic Jams on the Road to Meaningful Use Report The “CPOE: Traffic Jams on the Road to Meaningful Use” report was compiled data from healthcare executives, managers and clinicians. The study provided detailed information on several criteria including current CPOE usage at healthcare organizations, product capabilities and vendor performance. About KLAS KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4,500 hospitals and over 2,500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com, or email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. About Eclipsys Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see www.eclipsys.com or email email@example.com. Statements in this news release concerning the implementation of and features and benefits provided by Eclipsys software, including clinical outcomes, safety, and efficiency, ARRA qualification, physician adoption, evidence-based content and services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and client-specific configuration of Eclipsys software can be complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. ARRA qualification requires compliance with standards that are still evolving, and satisfaction of those standards may be delayed. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys, The Outcomes Company, Sunrise Enterprise, Sunrise Pharmacy, Sunrise Clinical Analytics and Sunrise Patient Portal are either registered trademarks or trademarks of Eclipsys Corporation (or its subsidiaries) in the United States and certain other countries. Other product and company names in this news release are or may be trademarks of their respective companies.